$NRBO NeuroBo Pharmaceuticals, Inc. Insider Trading
Get free email notifications about insider trading in NeuroBo Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NeuroBo Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in NeuroBo Pharmaceuticals, Inc. for free.
CIK Number: 0001638287
IRS Number: 472389984
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NRBO
Company Address: 200 BERKELEY ST. FL 19 BOSTON 02116
Phone number: (857) 702-9600
Former name: Gemphire Therapeutics Inc., date of change: 2015-03-31
Former name: NeuroBo Therapeutics, Inc.
Market Capitalization: $97.34M
Prev close: $10.72
Average Daily Volume: 9,037
Days Low: $10.25
Year Low: $7.25
Year High: $13.98
NeuroBo Pharmaceuticals, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 03 2020 | GEMP | NeuroBo Pharmaceut ... | Swirsky Douglas J | Director | Option Exercise | A | 6.04 | 60,000 | 362,400 | 60,000 | |
Jan 15 2020 | GEMP | NeuroBo Pharmaceut ... | Salsbury Michael | Director | Option Exercise | A | 8.39 | 60,000 | 503,400 | 60,000 | |
Jan 15 2020 | GEMP | NeuroBo Pharmaceut ... | Oh Jeong Gyun | Director | Option Exercise | A | 8.39 | 60,000 | 503,400 | 60,000 | |
Jan 15 2020 | GEMP | NeuroBo Pharmaceut ... | Kim Na Yeon | Director | Option Exercise | A | 8.39 | 60,000 | 503,400 | 60,000 | |
Jan 15 2020 | GEMP | NeuroBo Pharmaceut ... | Jeong Tae Heum | Director | Option Exercise | A | 8.39 | 60,000 | 503,400 | 60,000 | |
Jan 15 2020 | GEMP | NeuroBo Pharmaceut ... | Gullans Steven R. Ph.D. | Director | Option Exercise | A | 8.39 | 60,000 | 503,400 | 60,000 | |
Jan 15 2020 | GEMP | NeuroBo Pharmaceut ... | GROVES JASON L | Director | Option Exercise | A | 8.39 | 60,000 | 503,400 | 60,000 | |
Jan 02 2020 | GEMP | NeuroBo Pharmaceut ... | Versavel Mark | Chief Medical Offic ... | Option Exercise | A | 0.63 | 45,724 | 28,806 | 45,724 | |
Jan 02 2020 | GEMP | NeuroBo Pharmaceut ... | Versavel Mark | Chief Medical Offic ... | Option Exercise | A | 0.63 | 297,206 | 187,240 | 297,206 | |
Jan 02 2020 | GEMP | NeuroBo Pharmaceut ... | Oh Jeong Gyun | Director | Grant | A | 0.00 | 240,051 | 0 | 240,051 | 0 to 240.1 K |
Jan 02 2020 | GEMP | NeuroBo Pharmaceut ... | Oh Jeong Gyun | Director | Grant | A | 0.00 | 1,817,842 | 0 | 1,817,842 | 0 to 1.8 M |
Jan 02 2020 | GEMP | NeuroBo Pharmaceut ... | Kim Na Yeon | Director | Grant | A | 0.00 | 1,864,799 | 0 | 1,864,799 | 0 to 1.9 M |
Jan 02 2020 | GEMP | NeuroBo Pharmaceut ... | Kim Na Yeon | Director | Grant | A | 0.00 | 1,121,190 | 0 | 1,121,190 | 0 to 1.1 M |
Jan 02 2020 | GEMP | NeuroBo Pharmaceut ... | Kim Na Yeon | Director | Grant | A | 0.00 | 4,335,800 | 0 | 4,335,800 | 0 to 4.3 M |
Jul 26 2019 | GEMP | Gemphire Therapeut ... | SASSINE ANDY | Director | Grant | A | 0.00 | 15,000 | 0 | 151,264 | 136.3 K to 151.3 K (+11.01 %) |
View all NeuroBo Pharmaceuticals, Inc. insider transactions.